PubMed reference (NNMT inhibition & metabolic health)
The VEGFR2-Akt-eNOS angiogenic cascade increases blood vessel formation by 129-152% in preclinical studies
The peptides used come from licensed 503A compounding pharmacies with FDA-mandated sterile manufacturing standards and third-party testing on each batch
However, to achieve safe and meaningful results from peptide therapy, your provider must not only understand the science behind peptides, but also understand your unique biology
Dosage Guidelines by Treatment Goal Acute injury recovery: 500750mcg daily for 24 weeks Chronic condition management: 250500mcg daily for 612 weeks Gut health support: 250500mcg daily for 48 weeks General wellness and prevention: 200300mcg daily, 5 days per week Important: Always consult with a healthcare provider before starting BPC-157 therapy
Signs You May Need a Dose Adjustment Unexpected side effects such as nausea or dizziness Insufficient symptom improvement Changes in weight or other health markers How to Safely Adjust Dosage Always communicate with your healthcare provider before making any changes
